Skip to main content
Top
Published in: Journal of General Internal Medicine 2/2016

01-02-2016 | Editorial

The Veterans Choice Act and Dual Health System Use

Author: Walid F. Gellad, MD, MPH

Published in: Journal of General Internal Medicine | Issue 2/2016

Login to get access

Excerpt

The Veterans Access, Choice and Accountability Act (Choice Act), formally enacted on August 7, 2014, arose largely in response to outrage about delays in veteran access to health care and falsification of wait time records by Veterans Administration (VA) employees.1 The law includes a number of provisions to improve care for veterans, including increasing health care staffing and residency training positions, streamlining employee disciplinary procedures, improving treatment of military sexual trauma, and establishing a Presidential Commission on Care to evaluate access to VA health care. The most well-known, and perhaps controversial, provision is the Choice Program, which established a mechanism for eligible veterans to receive care outside the VA for 3 years. Veterans unable to schedule an appointment within 30 days of their preferred date or who live more than 40 miles from a VA facility are now eligible to receive care from non-VA providers. However, many of these veterans will also continue to use VA facilities and services, and this ‘dual use’ of health care systems may lead to care fragmentation and its ensuing adverse consequences. This commentary describes the problems of dual use and care fragmentation, the complexity of the Choice Program, and some ideas for ensuring its safe and effective implementation. …
Literature
1.
go back to reference Chokshi DA. Improving Health Care for Veterans—A Watershed Moment for the VA. N Engl J Med. 2014;371(4):297–9.CrossRefPubMed Chokshi DA. Improving Health Care for Veterans—A Watershed Moment for the VA. N Engl J Med. 2014;371(4):297–9.CrossRefPubMed
Metadata
Title
The Veterans Choice Act and Dual Health System Use
Author
Walid F. Gellad, MD, MPH
Publication date
01-02-2016
Publisher
Springer US
Published in
Journal of General Internal Medicine / Issue 2/2016
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-015-3492-2

Other articles of this Issue 2/2016

Journal of General Internal Medicine 2/2016 Go to the issue

Clinical Practice: Clinical Images

Hypertriglyceridemia-Induced Pancreatitis

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.